February 20, 2017 / 7:46 AM / 10 months ago

BRIEF-Biohit H2 operating loss flat at EUR 1.3 mln

Feb 20 (Reuters) - Biohit Oyj:

* H2 net sales 4.4 million euros ($4.67 million) versus 2.5 million euros year ago

* H2 operating loss 1.3 million euros versus loss 1.4 million euros year ago

* Board of directors proposes to annual general meeting that no dividend be paid for financial year

* China’s operations are in Biohit’s focus in 2017

* Expects to complete reduction of joint venture share capital during Q1 of 2017

* Estimates its non-comparable operating result to turn clearly positive for 2017

* Net sales growth is expected in 2017

* Company does not assess when comparable result will turn to positive Source text for Eikon: Further company coverage: ($1 = 0.9416 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below